Susanna Dunachie
#167,808
Most Influential Person Now
Researcher
Susanna Dunachie's AcademicInfluence.com Rankings
Susanna Dunachiebiology Degrees
Biology
#13897
World Rank
#17496
Historical Rank
Biotechnology
#281
World Rank
#283
Historical Rank
Download Badge
Biology
Susanna Dunachie's Degrees
- Masters Biotechnology Imperial College London
Why Is Susanna Dunachie Influential?
(Suggest an Edit or Addition)According to Wikipedia, Susanna Jane Dunachie is a British microbiologist who is Professor of Infectious Diseases at the University of Oxford. Her work considers microbiology and immunology to better understand bacterial infection and accelerate the development of vaccines. She has focused on melioidosis, scrub typhus and tuberculosis. During the COVID-19 pandemic, she studied T cell immunity to severe acute respiratory syndrome coronavirus 2.
Susanna Dunachie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2020) (3297)
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022) (1818)
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020) (1480)
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (2020) (1079)
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020) (884)
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (2021) (850)
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (2021) (812)
- Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans (2003) (607)
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021) (576)
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2022) (529)
- Antibody evasion by the P.1 strain of SARS-CoV-2 (2021) (427)
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study (2021) (423)
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (2021) (415)
- Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. (2005) (399)
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (2021) (373)
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2020) (367)
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (2020) (331)
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum (2022) (306)
- Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. (2005) (262)
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (2020) (228)
- The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017 (2019) (217)
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine (2021) (191)
- Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis (2020) (186)
- Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers1 (2005) (170)
- A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge (2006) (168)
- Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. (2005) (164)
- Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria1 (2005) (136)
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (130)
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (130)
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients (2020) (120)
- Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial (2008) (119)
- Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. (2005) (113)
- A blood atlas of COVID-19 defines hallmarks of disease severity and specificity (2021) (112)
- Prime-boost strategies for malaria vaccine development (2003) (112)
- Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study (2021) (100)
- Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia (2015) (98)
- A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS. (2006) (95)
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial (2021) (93)
- Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern (2021) (93)
- Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. (2006) (90)
- T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2020) (88)
- The double burden of diabetes and global infection in low and middle-income countries (2018) (87)
- Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming (2017) (83)
- Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720. (2005) (81)
- Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2021) (80)
- The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh (2018) (75)
- Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length Plasmodium falciparum Circumsporozoite Protein (2006) (73)
- Host Responses to Melioidosis and Tuberculosis Are Both Dominated by Interferon-Mediated Signaling (2013) (63)
- T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients (2015) (57)
- Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial (2021) (56)
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (54)
- Melioidosis in Thailand: Present and Future (2018) (54)
- Consensus on the Development of Vaccines against Naturally Acquired Melioidosis (2015) (52)
- T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study (2021) (51)
- T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study (2021) (51)
- Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data (2019) (49)
- Improving the estimation of the global burden of antimicrobial resistant infections. (2019) (49)
- Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection (2013) (48)
- A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 (2020) (47)
- Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (47)
- Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 (2020) (47)
- Potent cross-reactive antibodies following Omicron breakthrough in vaccinees (2022) (46)
- The impact of viral mutations on recognition by SARS-CoV-2 specific T cells (2021) (45)
- Mapping routine measles vaccination in low- and middle-income countries (2020) (44)
- Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. (2021) (43)
- Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis (2017) (42)
- Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection (2020) (40)
- Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum (2022) (39)
- Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand (2015) (38)
- T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study (2021) (37)
- Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2 (2021) (36)
- Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials (2021) (36)
- Diabetes alters immune response patterns to acute melioidosis in humans (2019) (35)
- Characterization of the Specificity, Functionality, and Durability of Host T‐Cell Responses Against the Full‐Length Hepatitis E Virus (2016) (34)
- Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naïve and Malaria-Exposed Individuals (2006) (33)
- T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis (2015) (30)
- Infection with Burkholderia pseudomallei – immune correlates of survival in acute melioidosis (2017) (30)
- Human MAIT cells show metabolic quiescence with rapid glucose‐dependent upregulation of granzyme B upon stimulation (2018) (30)
- Rapid and Sensitive Multiplex Detection of Burkholderia pseudomallei-Specific Antibodies in Melioidosis Patients Based on a Protein Microarray Approach (2016) (27)
- Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses (2021) (27)
- Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1 (2008) (27)
- Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (2021) (25)
- Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS) (2021) (25)
- Co-evolutionary signals identify Burkholderia pseudomallei survival strategies in a hostile environment. (2021) (25)
- Antibodies in Melioidosis: The Role of the Indirect Hemagglutination Assay in Evaluating Patients and Exposed Populations (2018) (24)
- Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model (2015) (24)
- The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria (2020) (23)
- Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients (2021) (22)
- Melioidosis in Bangladesh: A Clinical and Epidemiological Analysis of Culture-Confirmed Cases (2018) (21)
- Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection. (2021) (19)
- MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines (2009) (19)
- Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV (2022) (19)
- Divergent trajectories of antiviral memory after SARS-CoV-2 infection (2021) (18)
- Immune response to recombinant Burkholderia pseudomallei FliC (2018) (16)
- MIG and the Regulatory Cytokines IL-10 and TGF-β1 Correlate with Malaria Vaccine Immunogenicity and Efficacy (2010) (16)
- Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (15)
- Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (15)
- A nonsense mutation in TLR5 is associated with survival and reduced IL-10 and TNF-α levels in human melioidosis (2017) (14)
- Profiling the host response to malaria vaccination and malaria challenge (2015) (14)
- Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting (2016) (13)
- Burkholderia pseudomallei induces IL-23 production in primary human monocytes (2016) (13)
- Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity (2021) (12)
- Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection (2021) (10)
- Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine (2009) (10)
- Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (2021) (10)
- Smartphones for community health in rural Cambodia: A feasibility study (2018) (10)
- Role of Burkholderia pseudomallei–Specific IgG2 in Adults with Acute Melioidosis, Thailand (2021) (9)
- Characterization of the rhesus macaque (Macaca mulatta) scrub typhus model: Susceptibility to intradermal challenge with the human pathogen Orientia tsutsugamushi Karp (2018) (9)
- Strong interferon-gamma mediated cellular immunity to scrub typhus demonstrated using a novel whole cell antigen ELISpot assay in rhesus macaques and humans (2017) (9)
- Human Immune Responses to Melioidosis and Cross-Reactivity to Low-Virulence Burkholderia Species, Thailand (2020) (9)
- Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries (2020) (8)
- Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial (2011) (8)
- The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses (2022) (7)
- Melioidosis DS rapid test: A standardized serological dipstick assay with increased sensitivity and reliability due to multiplex detection (2020) (7)
- Clinical Epidemiology of Septic Arthritis Caused by Burkholderia pseudomallei and Other Bacterial Pathogens in Northeast Thailand (2017) (7)
- Serum From Melioidosis Survivors Diminished Intracellular Burkholderia pseudomallei Growth in Macrophages: A Brief Research Report (2020) (6)
- SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination (2022) (6)
- A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75 (2022) (6)
- Correction: The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh (2020) (6)
- Equity for excellence in academic institutions: a manifesto for change (2021) (5)
- Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus (2022) (5)
- A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model (2022) (4)
- Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses (2021) (4)
- A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (2021) (4)
- Accelerated waning of the humoral response to SARS-CoV-2 vaccines in obesity (2022) (4)
- Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern (2021) (3)
- Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers (2022) (3)
- Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2 (2022) (3)
- BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis (2021) (3)
- Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine (2021) (3)
- SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients. (2022) (3)
- mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals (2022) (3)
- Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19 (2022) (3)
- Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study (2022) (2)
- Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant (2022) (2)
- Global Antibiotic Consumption in Humans, 2000 to 2018: A Spatial Modelling Study (2020) (2)
- Real gains but practical limitations to glycaemic control with insulin in type 2 diabetes (2004) (2)
- Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2021) (2)
- Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination (2022) (2)
- Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis (2022) (2)
- Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection (2021) (2)
- Correction: Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine (2011) (1)
- Radiological features do not predict failure of two-stage arthroplasty for prosthetic joint infection: a retrospective case–control study (2014) (1)
- Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6 (2022) (1)
- Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study (2022) (1)
- Corrigendum to “MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines” [J. Immunol. Methods 340 (2009) 33–41] (2011) (1)
- Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease (2021) (1)
- Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming (2017) (1)
- Automating the generation of antimicrobial resistance surveillance reports: a proof-of-concept study in seven hospitals in seven countries (2020) (1)
- Co-evolutionary signals from Burkholderia pseudomallei genomics identify its survival strategies and highlight improving environmental health as prevention policy (2021) (1)
- T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network (2022) (1)
- Correction: A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model (2023) (0)
- Co-evolutionary signals from Burkholderia pseudomallei population genomics highlight its survival strategy in a hostile environment (2020) (0)
- The CINAMR (Clinical Information Network-Antimicrobial Resistance) Project: A pilot microbial surveillance using hospitals linked to regional laboratories in Kenya: Study Protocol (2022) (0)
- The Search for a Malaria Vaccine: Clinical Trials of DNA-MVA and other Prime-Boost Approaches (2003) (0)
- DOP20 Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD Consortium (2022) (0)
- Using DNA and Viral Vectors in Healthy Heterologous Prime-Boost Vaccine Regimens Differential Immunogenicity of Various (2004) (0)
- 1163: BOTH VEDOLIZUMAB AND ANTI-TNF THERAPY ARE ASSOCIATED WITH ATTENUATION OF SEROLOGICAL AND NEUTRALIZING RESPONSES TO SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE (2022) (0)
- Geospatial mapping of the global prevalence of antimicrobial resistant Salmonella Typhi & Paratyphi A (2019) (0)
- Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens (2023) (0)
- A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus (2022) (0)
- Infection with Burkholderia pseudomallei – immune correlates of survival in acute melioidosis (2017) (0)
- Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries (Preprint) (2020) (0)
- Burkholderia pseudomallei induces IL-23 production in primary human monocytes (2015) (0)
- Reynolds R, Goudet A, Jenjaroen K, Sumonwiriya M, Rinchai D, Musson J, (2015) (0)
- Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses (2023) (0)
- Endemic hepatitis B virus (HBV) among hospital in-patients in Bangladesh, including evidence of occult infection (2020) (0)
- BpOmpW Antigen Stimulates the Necessary Immune Correlates of Protection Against Melioidosis (2021) (0)
- Mitochondrial Ultrastructure and Activity Are Differentially Regulated by Glycolysis-, Krebs Cycle-, and Microbiota-Derived Metabolites in Monocytes (2022) (0)
- Erratum to: Burkholderia pseudomallei induces IL-23 production in primary human monocytes (2016) (0)
- Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response (2023) (0)
- Antimicrobial drug resistance in Shigella isolates globally, 1990 to 2018: A systematic review of the literature. (2020) (0)
- Erratum to: Burkholderia pseudomallei induces IL-23 production in primary human monocytes (2016) (0)
- HIGH-INTERMEDIATE ENDEMIC PREVALENCE OF HEPATITIS B VIRUS AMONGST FEBRILE PATIENTS IN BANGLADESH, INCLUDING EVIDENCE OF OCCULT INFECTION (2019) (0)
- Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (0)
- Impact of shipping temperature on cell viability and T cell responses to bacterial antigens (2023) (0)
- Global antibiotic consumption: A modelling study (2020) (0)
This paper list is powered by the following services:
Other Resources About Susanna Dunachie
What Schools Are Affiliated With Susanna Dunachie?
Susanna Dunachie is affiliated with the following schools:
